Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes

Human Reproduction

Volumn 30, Issue 6, 2015, Pages 1447-1453

  De Wilde, Marlieke A ^a   Goverde, Angelique J ^a   Veltman Verhulst, Susanne M ^a   Eijkemans, Marinus J C ^a   Franx, Arie ^a   Fauser, Bart C J M ^a   Koster, Maria P H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

gestational diabetes; PCOS; pregnancy

Indexed keywords

INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MULTICENTER STUDY (TOPIC); OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; SECOND TRIMESTER PREGNANCY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; COHORT ANALYSIS; COMPLICATION; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; INSULIN RESISTANCE; METABOLISM; MULTIVARIATE ANALYSIS; PREGNANCY;

ADULT; BLOOD GLUCOSE; COHORT STUDIES; DIABETES, GESTATIONAL; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MULTIVARIATE ANALYSIS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 84939601451     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev072     Document Type: Article

References (32)

1. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S103-S105.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-S69.
3. American Diabetes Association. Standards of medical care in diabetes- 2012. Diabetes Care 2012;35(Suppl 1):S11-S63.
4. Anderson DC. Sex-hormone-binding globulin. Clin Endocrinol (Oxf) 1974; 3:69-96.
5. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006;12:673-683.
6. Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction 2010;140:365-371.
7. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999; 180:903-916.
8. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short-and long-term implications for mother and fetus. J Nutr 2003;133:1674S-1683S.
9. Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, Dietz PM. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care 2007;30:2070-2076.
10. Daan NM, Louwers YV, Koster MP, Eijkemans MJ, de Rijke YB, Lentjes EW, Fauser BC, Laven JS. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil Steril 2014;102:1444-1451.e3.
11. de Wilde MA, Veltman-Verhulst SM, Goverde AJ, Lambalk CB, Laven JS, Franx A, Koster MP, Eijkemans MJ, Fauser BC. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome. Hum Reprod 2014;29:1327-1336.
12. Dmitrovic R, Katcher HI, Kunselman AR, Legro RS. Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome. Obstet Gynecol 2011;118:878-885.
13. Falbo A, Rocca M, Russo T, D'Ettore A, Tolino A, Zullo F, Orio F, Palomba S. Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes. J Ovarian Res 2010;3:23.
14. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012; 97:28-38.
15. Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. HumReprod 2009;24:710-717.
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol 2005;4:198-203.
17. Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL. The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. J Clin Endocrinol Metab 2003; 88:1528-1533.
18. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001;24:1602-1607.
19. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 2011; 204:558-558.
20. Landon MB, Gabbe SG. Gestational diabetes mellitus. Obstet Gynecol 2011; 118:1379-1393.
21. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007;30(Suppl 2): S251-S260.
22. Nolan CJ. Controversies in gestational diabetes. Best Pract Res Clin Obstet Gynaecol 2011;25:37-49.
23. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;370:685-697.
24. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988;67:460-464.
25. Reece EA, Leguizamon G,Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009;373:1789-1797.
26. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-47.
27. Ryan EA. Hormones and insulin resistance during pregnancy. Lancet 2003; 362:1777-1778.
28. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002;17:2573-2579.
29. Thadhani R, Wolf M, Hsu-Blatman K, Sandler L, Nathan D, Ecker JL. First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. Am J Obstet Gynecol 2003;189:171-176.
30. Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 2004;27:861-868.
31. van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 1997;67: 452-458.
32. Yamashita H, Shao J, Friedman JE. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus. Clin Obstet Gynecol 2000;43:87-98.